OncoMatch/Clinical Trials/NCT06622941
Study to ONO-4538 in Patients With Rhabdoid Tumor
Is NCT06622941 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies ONO-4538 for rhabdoid tumor.
Treatment: ONO-4538 — Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Check if I qualifyExtracted eligibility criteria
Cancer type
Glioblastoma
Prior therapy
Min 1 prior line
Must have received: chemotherapy — for rhabdoid Tumors
Patients who are refractory or intolerant to one or more regimens of chemotherapy for rhabdoid Tumors
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify